![The Biden administration’s limit on drug industry middlemen backfires, pharmacists say. (Dreamstime/TNS)
A person in a pharmacist's coat holds a bottle.](https://www.sun-sentinel.com/wp-content/uploads/2023/11/US-NEWS-HEALTH-DRUG-INDUSTRY-MIDDLEMEN-DMT.jpg?w=542)
PBMs, or pharmacy benefit managers, sit at the center of the U.S. supply chain for drugs, where they say they negotiate lower prices for insurers — including Medicare — and for employers and their workers.
Subscribe to continue reading this article.
Already subscribed? To login in, click here.
Originally Published: